EMA Grants LIfT 'ATMP Classification'
The European Medicines Agency (EMA) have classified LIfT's enhanced allogeneic granulocyte therapy as a somatic cell therapy MP, a type...
May 1, 2017
LIfT BioSciences Wins Medcity Award
LIfT BioSciences has been announced as one of the winners of Medcity’s Collaborate to Innovate Award and grant. The focus for the project...
Mar 23, 2017
Mar 20, 2017
LIfT BioSciences Joins Stevenage Bioscience Catalyst
LIfT BioSciences has joined the UK's leading BioIncubator, Stevenage Bioscience Catalyst (SBC), for the UK's most promising SMEs in the...
Feb 6, 2017
LIfT BioSciences Gains Initial Funding into Pancreatic Cancer Research
LIfT BioSciences has successfully secured initial funding into its potentially breakthrough Cell Therapy for Pancreatic Cancer. The...
Jan 31, 2017
